SCLXW Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)—0.0% YoY
Profit margin0.0%
Market cap—
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- 0.0%
- Operating margin
- -373.5%
- Revenue growth YoY
- 72.1%
- Dividend yield
- —
- Beta
- 1.71
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
8 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Scilex Holding Company
Company profileScilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company is headquartered in Palo Alto, California.
Classification
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 960 SAN ANTONIO ROAD, PALO ALTO, CA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Shares outstanding$0
52W high$0.65
52W low$0.07
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent